skip to navigation skip to content

Le Point International: Cancer vaccines: why BioNTech is betting on the UK


Thomas Roulet, Associate Professor in Organisation Theory and Deputy Director of the MBA programme at Cambridge Judge Business School, is quoted in this article mentioning AstraZeneca’s anti-Covid19 vaccine.

“This vaccine showed this country’s ability to create ecosystems that combine an innovative company, great research universities, the public health system, a teaching hospital, and a state willing to facilitate the process,” says Thomas.

Read the full article []